Latest Insider Transactions at Volitionrx LTD (VNRX)
This section provides a real-time view of insider transactions for Volitionrx LTD (VNRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of VOLITIONRX LTD to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of VOLITIONRX LTD's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 15
2025
|
Guy Archibald Innes |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+6.97%
|
-
|
|
Dec 09
2024
|
Cameron John Reynolds President and CEO |
BUY
Open market or private purchase
|
Direct |
139,811
+6.19%
|
$0
$0.57 P/Share
|
|
Dec 09
2024
|
Jacob Vincent Micallef Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
43,691
+9.97%
|
$0
$0.57 P/Share
|
|
Dec 09
2024
|
Timothy I Still |
BUY
Open market or private purchase
|
Direct |
87,382
+5.55%
|
$0
$0.57 P/Share
|
|
Dec 09
2024
|
Guy Archibald Innes |
BUY
Open market or private purchase
|
Direct |
174,764
+22.07%
|
$0
$0.57 P/Share
|
|
Dec 01
2024
|
Salvatore Thomas Butera CEO, Volition Veterinary |
BUY
Grant, award, or other acquisition
|
Direct |
16,871
+5.43%
|
-
|
|
Dec 01
2024
|
Andrew Retter Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,365
+6.84%
|
-
|
|
Dec 01
2024
|
Terig Hughes Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,683
+3.26%
|
-
|
|
Dec 01
2024
|
Kim Nguyen |
BUY
Grant, award, or other acquisition
|
Direct |
8,648
+10.15%
|
-
|
|
Dec 01
2024
|
Ann Louise Batchelor Group Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,143
+10.28%
|
-
|
|
Dec 01
2024
|
Alan Colman |
BUY
Grant, award, or other acquisition
|
Direct |
12,972
+5.33%
|
-
|
|
Dec 01
2024
|
Jasmine Kway CEO, Singapore Volition |
BUY
Grant, award, or other acquisition
|
Direct |
15,169
+8.37%
|
-
|
|
Dec 01
2024
|
Ethel Rubin |
BUY
Grant, award, or other acquisition
|
Direct |
8,648
+26.78%
|
-
|
|
Dec 01
2024
|
Gael Forterre Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,828
+2.98%
|
-
|
|
Dec 01
2024
|
Guy Archibald Innes |
BUY
Grant, award, or other acquisition
|
Direct |
17,296
+3.76%
|
-
|
|
Dec 01
2024
|
Nicholas Plummer GC, Volition Diagnostics |
BUY
Grant, award, or other acquisition
|
Direct |
11,527
+6.52%
|
-
|
|
Dec 01
2024
|
Rodney Gerard Rootsaert Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
7,302
+5.13%
|
-
|
|
Nov 06
2024
|
Timothy I Still |
BUY
Grant, award, or other acquisition
|
Direct |
1,400,000
+45.83%
|
-
|
|
Oct 04
2024
|
Jacob Vincent Micallef Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,200
-1.46%
|
$0
$0.88 P/Share
|
|
Oct 04
2024
|
Nicholas Plummer GC, Volition Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
8,146
-5.04%
|
$0
$0.88 P/Share
|
|
Oct 04
2024
|
Gael Forterre Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,433
-3.44%
|
$0
$0.88 P/Share
|
|
Oct 04
2024
|
Rodney Gerard Rootsaert Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
4,620
-3.49%
|
$0
$0.88 P/Share
|
|
Oct 04
2024
|
Ann Louise Batchelor Group Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,110
-5.67%
|
$0
$0.88 P/Share
|
|
Oct 04
2024
|
Salvatore Thomas Butera CEO, Volition Veterinary |
SELL
Payment of exercise price or tax liability
|
Direct |
5,834
-2.06%
|
$0
$0.88 P/Share
|
|
Sep 30
2024
|
Ethel Rubin |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+50.0%
|
-
|
|
Sep 28
2024
|
Ann Louise Batchelor Group Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,604
-4.95%
|
$0
$0.58 P/Share
|
|
Sep 28
2024
|
Salvatore Thomas Butera CEO, Volition Veterinary |
SELL
Payment of exercise price or tax liability
|
Direct |
5,230
-1.82%
|
$0
$0.58 P/Share
|
|
Sep 28
2024
|
Rodney Gerard Rootsaert Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
4,158
-3.04%
|
$0
$0.58 P/Share
|
|
Sep 28
2024
|
Nicholas Plummer GC, Volition Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
1,497
-0.92%
|
$0
$0.58 P/Share
|
|
Sep 28
2024
|
Jacob Vincent Micallef Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,950
-1.37%
|
$0
$0.58 P/Share
|
|
Sep 28
2024
|
Gael Forterre Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,824
-2.97%
|
$0
$0.58 P/Share
|
|
Sep 01
2024
|
Michel Gaetan Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,671
+3.81%
|
-
|
|
Sep 01
2024
|
Nicholas Plummer GC, Volition Diagnostics |
BUY
Grant, award, or other acquisition
|
Direct |
12,043
+6.87%
|
-
|
|
Sep 01
2024
|
Guy Archibald Innes |
BUY
Grant, award, or other acquisition
|
Direct |
18,342
+4.14%
|
-
|
|
Sep 01
2024
|
Jacob Vincent Micallef Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
47,837
+11.71%
|
-
|
|
Sep 01
2024
|
Jasmine Kway CEO, Singapore Volition |
BUY
Grant, award, or other acquisition
|
Direct |
15,668
+9.41%
|
-
|
|
Sep 01
2024
|
Andrew Retter Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,784
+7.65%
|
-
|
|
Sep 01
2024
|
Gael Forterre Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,240
+5.92%
|
-
|
|
Sep 01
2024
|
Kim Nguyen |
BUY
Grant, award, or other acquisition
|
Direct |
9,171
+11.9%
|
-
|
|
Sep 01
2024
|
Phillip Barnes |
BUY
Grant, award, or other acquisition
|
Direct |
9,171
+14.21%
|
-
|
|
Sep 01
2024
|
Rodney Gerard Rootsaert Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
15,258
+10.05%
|
-
|
|
Sep 01
2024
|
Salvatore Thomas Butera CEO, Volition Veterinary |
BUY
Grant, award, or other acquisition
|
Direct |
35,783
+11.06%
|
-
|
|
Sep 01
2024
|
Terig Hughes Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,493
+3.58%
|
-
|
|
Sep 01
2024
|
Ann Louise Batchelor Group Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,731
+10.81%
|
-
|
|
Sep 01
2024
|
Alan Colman |
BUY
Grant, award, or other acquisition
|
Direct |
13,757
+5.95%
|
-
|
|
Sep 01
2024
|
Cameron John Reynolds President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
103,243
+4.96%
|
-
|
|
Aug 20
2024
|
Guy Archibald Innes |
BUY
Open market or private purchase
|
Direct |
150,000
+26.95%
|
$0
$0.67 P/Share
|
|
Aug 15
2024
|
Michel Gaetan Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,250
+6.24%
|
-
|
|
Aug 15
2024
|
Mickie Henshall |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+13.44%
|
-
|
|
Aug 15
2024
|
Terig Hughes Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,500
+5.28%
|
-
|